Pulse Biosciences (PLSE) Assets Average (2016 - 2026)

Pulse Biosciences has reported Assets Average for 11 years, with the latest figure at $105.1 million in Q2 2026.

• On a quarterly basis, Assets Average fell 17.16% year-over-year to $105.1 million in Q2 2026; TTM through Jun 2026 was $105.1 million, a 17.16% decrease from a year earlier, with the FY2025 full-year figure at $113.5 million, up 18.47% from the prior year.
• Assets Average was $105.1 million for Q2 2026 at Pulse Biosciences, up from $101.7 million in the prior quarter.
• The five-year high for Assets Average was $132.9 million in Q1 2025, with the low at $40.1 million in Q2 2022.
• Average Assets Average over 5 years is $80.9 million, with a median of $72.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Assets Average tumbled 50.1% in 2022, then soared 183.1% in 2025.
• Over 5 years, Assets Average stood at $82.7 million in 2022, then retreated by 24.39% to $62.5 million in 2023, then jumped by 80.26% to $112.8 million in 2024, then decreased by 9.85% to $101.7 million in 2025, then advanced by 3.34% to $105.1 million in 2026.
• The last three Assets Average figures came in at $105.1 million (Q2 2026), $101.7 million (Q4 2025), and $114.5 million (Q3 2025), per Business Quant data.